DAVID BERRY

Business address
C/O Eleven Biotherapeutics, Inc., 215 First Street, Suite 400, Cambridge, MA, 02142
Top holdings (ownership)
OMGA
Get insider transactions for this reporting owner
DAVID BERRY has filed 15 SEC EDGAR filings since 08 Nov 2002

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
3 Open Document Open Filing 3 22 Oct 2025 17 Oct 2025 001-42383
4 Open Document Open Filing FORM 4 SUBMISSION 03 Aug 2021 03 Aug 2021 001-40657
4 Open Document Open Filing FORM 4 SUBMISSION 30 Jul 2021 29 Jul 2021 001-40657
3 Open Document Open Filing FORM 3 SUBMISSION 29 Jul 2021 29 Jul 2021 001-40657
4 Open Document Open Filing 4 22 May 2020 20 May 2020 001-38901
4 Open Document Open Filing 4 24 May 2019 22 May 2019 001-38901
3 Open Document Open Filing 3 08 May 2019 08 May 2019 001-38901
4 Open Document Open Filing FORM 4 10 Jun 2016 08 Jun 2016 001-36296
4 Open Document Open Filing FORM 4 SUBMISSION 18 Jun 2015 16 Jun 2015 001-36296
4 Open Document Open Filing FORM 4 SUBMISSION 24 Mar 2014 20 Mar 2014 001-36296
3 Open Document Open Filing FORM 3 05 Feb 2014 05 Feb 2014 001-36296
4 Open Document Open Filing OWNERSHIP DOCUMENT 21 Mar 2013 19 Mar 2013 001-32543